Relmada Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.30 M | $677,119 | 0.00% | 4.32% |
| VANGUARD GROUP INC | 02/11/2025 | 1.26 M | $653,487 | 0.00% | 4.16% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.23 M | $636,000 | 3.50% | 4.07% |
| BLACKROCK, INC. | 02/07/2025 | 593,326 | $308,530 | 4.48% | 1.97% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 495,146 | $257,476 | -32.39% | 1.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 302,838 | $157,516 | -0.55% | 1.00% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 224,846 | $116,920 | 0.00% | 0.75% |
| UBS GROUP AG | 02/14/2025 | 215,140 | $111,873 | 70.23% | 0.71% |
| ADVISORSHARES INVESTMENTS LLC | 02/14/2025 | 210,068 | $109,235 | 206.54% | 0.70% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 209,900 | $109,148 | 64.89% | 0.70% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 206,657 | $107,462 | 0.00% | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 200,825 | $104,429 | 295.13% | 0.67% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 198,900 | $103,428 | -17.98% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 164,513 | $85,547 | 535.48% | 0.55% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 01/22/2025 | 163,336 | $84,935 | -83.71% | 0.54% |
| RBF CAPITAL, LLC | 02/14/2025 | 163,261 | $84,896 | -1.34% | 0.54% |
| BARCLAYS PLC | 02/13/2025 | 145,999 | $76,000 | 0.00% | 0.48% |
| CITADEL ADVISORS LLC | 02/14/2025 | 129,800 | $67,496 | 93.44% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 127,579 | $66,341 | -33.31% | 0.42% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 124,773 | $65,000 | 15.09% | 0.41% |
| STATE STREET CORP | 02/14/2025 | 106,735 | $55,502 | 7.56% | 0.35% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 102,087 | $53,085 | 3.18% | 0.34% |
| ROSALIND ADVISORS, INC. | 02/14/2025 | 100,000 | $52,000 | 100.00% | 0.33% |
| MGO ONE SEVEN LLC | 02/14/2025 | 100,000 | $52,000 | 0.00% | 0.33% |
| NORTHERN TRUST CORP | 02/14/2025 | 84,282 | $43,827 | 12.80% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 72,600 | $37,752 | -59.91% | 0.24% |
| CITIGROUP INC | 02/12/2025 | 62,949 | $32,734 | 0.00% | 0.21% |
| APRICUS WEALTH, LLC | 01/21/2025 | 48,962 | $25,460 | -37.99% | 0.16% |
| CITADEL ADVISORS LLC | 02/14/2025 | 46,500 | $24,180 | -8.10% | 0.15% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 45,602 | $23,713 | -71.08% | 0.15% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 40,270 | $20,940 | -0.25% | 0.13% |
| JPMORGAN CHASE & CO | 02/12/2025 | 37,700 | $19,604 | -88.03% | 0.12% |
| SEI INVESTMENTS CO | 02/11/2025 | 36,230 | $18,840 | -0.25% | 0.12% |
| CARTESIAN GROWTH CORP | 02/14/2025 | 31,975 | $16,627 | 0.00% | 0.11% |
| FMR LLC | 02/13/2025 | 30,062 | $15,632 | -74.21% | 0.10% |
| PENSIONMARK FINANCIAL GROUP, LLC | 02/12/2025 | 29,684 | $15,436 | -9.18% | 0.10% |
| 03/12/2025 | 28,000 | $14,560 | 100.00% | 0.09% | |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 01/27/2025 | 25,000 | $13,000 | 100.00% | 0.08% |
| WOLVERINE TRADING, LLC | 02/14/2025 | 24,200 | $11,108 | 14.69% | 0.08% |
| TORTOISE INVESTMENT MANAGEMENT, LLC | 02/07/2025 | 21,676 | $11,272 | 0.00% | 0.07% |
| MORGAN STANLEY | 02/14/2025 | 17,197 | $8,943 | -54.60% | 0.06% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 14,428 | $7,503 | -80.34% | 0.05% |
| SARGENT INVESTMENT GROUP, LLC | 01/27/2025 | 11,670 | $4,715 | -45.62% | 0.04% |
| BEAUMONT CAPITAL MANAGEMENT, LLC | 02/14/2025 | 11,006 | $5,723 | 100.00% | 0.04% |
| BEDEL FINANCIAL CONSULTING, INC. | 02/06/2025 | 10,000 | $3,800 | 0.00% | 0.03% |
| HEXAGON CAPITAL PARTNERS LLC | 02/07/2025 | 4,000 | $2,080 | 0.00% | 0.01% |
| AMERICAN CAPITAL ADVISORY, LLC | 01/28/2025 | 1,954 | $1,017 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 760 | $396 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 200 | $104 | -42.86% | 0.00% |
| 02/06/2025 | 102 | $53 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Relmada Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 89 institutional investors and hedge funds held shares of Relmada Therapeutics, Inc.. The most heavily invested institutionals were:
FRANKLIN RESOURCES INC: 1.3 M
VANGUARD GROUP INC: 1.26 M
ACADIAN ASSET MANAGEMENT LLC: 1.23 M
BlackRock, Inc.: 593,326
Palo Alto Investors LP: 495,146
GEODE CAPITAL MANAGEMENT, LLC: 302,838
27.84% of Relmada Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.16 M shares in the last 24 months. This purchase volume represents approximately $2.77 M in transactions.